Question 1

Does Franklin Templeton own SNDX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Franklin Templeton holds 2,286,499 shares of SNDX (Syndax Pharmaceuticals), worth $50M.

Question 2

How many shares of SNDX does Franklin Templeton own?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton holds 2,286,499 shares of SNDX (Syndax Pharmaceuticals).

Question 3

What is Franklin Templeton's SNDX position worth?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton's SNDX position is worth $50M.

Question 4

Is Franklin Templeton buying or selling SNDX?

Accepted Answer

In Q2 2026, Franklin Templeton increased its SNDX position by 136,420 shares (+6.3%).

Question 5

When did Franklin Templeton first buy SNDX?

Accepted Answer

Franklin Templeton first reported SNDX in its Q4 2023 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.3M	+6.3%	$50M	0.0%	$21.86	31
2026-Q1	Decreased	2.2M	-11.2%	$50.2M	0.0%	$21.40	0
2025-Q4	Increased	2.4M	+1.3%	$50.9M	0.0%	$20.74	30
2025-Q3	Increased	2.4M	+1.3%	$36.8M	0.0%	$15.56	29
2025-Q2	Increased	2.4M	+14.5%	$22.1M	0.0%	$9.04	33
2025-Q1	Increased	2.1M	+16.7%	$25.3M	0.0%	$13.18	33
2024-Q4	Increased	1.8M	+0.2%	$23.4M	0.0%	$12.52	28
2024-Q3	Increased	1.8M	+13.4%	$34.9M	0.0%	$18.89	33
2024-Q2	Increased	1.6M	+4.0%	$31.9M	0.0%	$20.53	30
2024-Q1	Increased	1.5M	+10.6%	$35.6M	0.0%	$23.80	32
2023-Q4	New	1.4M	-	$29.2M	0.0%	$21.61	40

SNDX11 quarters

SNDX
11 quarters